Leila E. Mansoor

5.6k total citations · 2 hit papers
62 papers, 3.4k citations indexed

About

Leila E. Mansoor is a scholar working on Infectious Diseases, General Health Professions and Epidemiology. According to data from OpenAlex, Leila E. Mansoor has authored 62 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Infectious Diseases, 38 papers in General Health Professions and 31 papers in Epidemiology. Recurrent topics in Leila E. Mansoor's work include HIV/AIDS Research and Interventions (53 papers), Adolescent Sexual and Reproductive Health (36 papers) and HIV, Drug Use, Sexual Risk (28 papers). Leila E. Mansoor is often cited by papers focused on HIV/AIDS Research and Interventions (53 papers), Adolescent Sexual and Reproductive Health (36 papers) and HIV, Drug Use, Sexual Risk (28 papers). Leila E. Mansoor collaborates with scholars based in South Africa, United States and Uganda. Leila E. Mansoor's co-authors include Quarraisha Abdool Karim, Salim S. Abdool Karim, Anneke Grobler, Tanuja N. Gengiah, Cheryl Baxter, Ros Dowse, Ayesha B. M. Kharsany, Janet Frohlich, Sengeziwe Sibeko and Koleka Mlisana and has published in prestigious journals such as Science, New England Journal of Medicine and Nature Medicine.

In The Last Decade

Leila E. Mansoor

57 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

2010 1.9k citations Quarraisha Abdool Karim, Salim S. Abdool Karim et al. Science profile →
Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women

2017 281 citations Nichole R. Klatt, Ryan K. Cheu et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leila E. Mansoor South Africa	21	2.2k	1.3k	1.2k	938	896	62	3.4k
Ayesha B. M. Kharsany South Africa	21	2.2k 1.0×	1.3k 1.0×	1.2k 1.0×	856 0.9×	795 0.9×	61	3.2k
Cheryl Baxter South Africa	24	3.0k 1.3×	1.9k 1.5×	1.2k 1.0×	1.1k 1.1×	908 1.0×	74	4.1k
Tanuja N. Gengiah South Africa	17	2.8k 1.3×	1.7k 1.4×	1.2k 1.0×	948 1.0×	643 0.7×	52	4.4k
Lut Van Damme United States	25	1.8k 0.8×	1.2k 0.9×	897 0.7×	712 0.8×	1.2k 1.3×	57	2.9k
Guy de Bruyn South Africa	31	2.2k 1.0×	1.5k 1.2×	1.3k 1.1×	640 0.7×	614 0.7×	99	3.6k
Janet Frohlich South Africa	20	2.0k 0.9×	1.1k 0.9×	1.3k 1.0×	761 0.8×	618 0.7×	41	3.1k
R. Scott McClelland United States	31	1.4k 0.6×	1.2k 0.9×	977 0.8×	623 0.7×	1.1k 1.2×	100	3.0k
Sengeziwe Sibeko South Africa	13	1.8k 0.8×	924 0.7×	738 0.6×	1.3k 1.4×	659 0.7×	28	2.9k
Ruanne V. Barnabas United States	35	2.7k 1.2×	3.0k 2.4×	1.5k 1.2×	586 0.6×	530 0.6×	198	4.8k
Léopold Zekeng Cameroon	35	2.4k 1.1×	1.2k 1.0×	716 0.6×	1.9k 2.0×	577 0.6×	101	3.8k

Countries citing papers authored by Leila E. Mansoor

Since Specialization

Citations

This map shows the geographic impact of Leila E. Mansoor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila E. Mansoor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila E. Mansoor more than expected).

Fields of papers citing papers by Leila E. Mansoor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila E. Mansoor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila E. Mansoor. The network helps show where Leila E. Mansoor may publish in the future.

Co-authorship network of co-authors of Leila E. Mansoor

This figure shows the co-authorship network connecting the top 25 collaborators of Leila E. Mansoor. A scholar is included among the top collaborators of Leila E. Mansoor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila E. Mansoor. Leila E. Mansoor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beesham, Ivana, et al.. (2025). Disclosure of oral pre-exposure prophylaxis use for HIV prevention among women enrolled in a contraceptive study: qualitative findings from Durban, South Africa. Frontiers in Global Women s Health. 5. 1505643–1505643.

Brown, Elizabeth R., Stephen Cherne, Ailton Sepulveda, et al.. (2025). Association of human papillomavirus on risk of HIV acquisition in African women: analyses from MTN-020/ASPIRE. JNCI Journal of the National Cancer Institute. 118(3). 485–491.

Gengiah, Tanuja N., Lara Lewis, Ishana Harkoo, et al.. (2025). Safety, tolerability, and pharmacokinetics of an annual tenofovir alafenamide silicone subdermal implant in South African women: a two-part, randomised, placebo-controlled, double-blind, first-in-human, phase 1 trial. The Lancet HIV. 12(8). e556–e567. 1 indexed citations

Husnik, Marla, Renee Heffron, James P. Hughes, et al.. (2024). Efficacy of the Dapivirine Vaginal Ring Accounting for Imperfect Adherence. AIDS and Behavior. 28(11). 3873–3882.

Browne, Erica N., Kristine Torjesen, Brenda Gati Mirembe, et al.. (2023). Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex. AIDS Care. 36(1). 80–86. 3 indexed citations

Beesham, Ivana, Cecilia Milford, Dvora Joseph Davey, et al.. (2023). Key stakeholders’ perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South Africa. African Journal of AIDS Research. 22(1). 18–26. 1 indexed citations

Garcia, Morgan, Sarah T. Roberts, Ashley Mayo, et al.. (2022). Integrating Gender-Based Violence Screening and Support into the Research Clinic Setting: Experiences from an HIV Prevention Open-Label Extension Trial in Sub-Saharan Africa. AIDS and Behavior. 27(4). 1277–1286. 2 indexed citations

Ngcapu, Sinaye, Farzana Osman, Veron Ramsuran, et al.. (2021). Transient association between semen exposure and biomarkers of genital inflammation in South African women at risk of HIV infection. Journal of the International AIDS Society. 24(6). e25766–e25766. 4 indexed citations

Montgomery, Elizabeth, Ariana W. K. Katz, Zoe Duby, et al.. (2021). Men’s Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe. AIDS and Behavior. 25(6). 1890–1900. 14 indexed citations

10.

Mansoor, Leila E., Halima Dawood, Kogieleum Naidoo, et al.. (2020). Importance of early identification of PrEP breakthrough infections in a generalized HIV epidemic: a case report from a PrEP demonstration project in South Africa. BMC Infectious Diseases. 20(1). 532–532. 4 indexed citations

11.

Mansoor, Leila E., Nonhlanhla Yende‐Zuma, Cheryl Baxter, et al.. (2019). Integrated provision of topical pre‐exposure prophylaxis in routine family planning services in South Africa: a non‐inferiority randomized controlled trial. Journal of the International AIDS Society. 22(9). e25381–e25381. 14 indexed citations

12.

Liebenberg, Lenine J. P., Lyle R. McKinnon, Nonhlanhla Yende‐Zuma, et al.. (2019). HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition. Nature Communications. 10(1). 5227–5227. 38 indexed citations

13.

Klatt, Nichole R., Ryan K. Cheu, Kenzie Birse, et al.. (2017). Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science. 356(6341). 938–945. 281 indexed citations breakdown →

14.

Mngadi, Kathryn, Jerome Amir Singh, Leila E. Mansoor, & Douglas Wassenaar. (2017). Undue inducement: a case study in CAPRISA 008. Journal of Medical Ethics. 43(12). 824–828. 7 indexed citations

15.

Mngadi, Kathryn, Janet Frohlich, Elizabeth Montague, et al.. (2015). Challenges with participant reimbursement: experiences from a post-trial access study. Journal of Medical Ethics. 41(11). 909–913. 2 indexed citations

16.

Tolley, Elizabeth E., Barbara Friedland, Mitzy Gafos, et al.. (2014). Socioeconomic and behavioral factors influencing choice, adherence, and success of microbicide formulations. UCL Discovery (University College London). 8 indexed citations

17.

Homan, Rick, Sarah Dlamini, Leila E. Mansoor, et al.. (2014). Introducing Microbicides: Estimated Cost of QI Approach and Tenofovir Gel Delivery with Family Planning Services in the CAPRISA 008 Trial. AIDS Research and Human Retroviruses. 30(S1). A284–A284. 1 indexed citations

18.

Dellar, Rachael, Quarraisha Abdool Karim, Leila E. Mansoor, et al.. (2014). The Preventive Misconception: Experiences from CAPRISA 004. AIDS and Behavior. 18(9). 1746–1752. 8 indexed citations

19.

Matthews, Lynn T., Sengeziwe Sibeko, Leila E. Mansoor, et al.. (2013). Women with Pregnancies Had Lower Adherence to 1% Tenofovir Vaginal Gel as HIV Preexposure Prophylaxis in CAPRISA 004, a Phase IIB Randomized-Controlled Trial. PLoS ONE. 8(3). e56400–e56400. 17 indexed citations

20.

Karim, Quarraisha Abdool, Salim S. Abdool Karim, Janet Frohlich, et al.. (2010). Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women. Science. 329(5996). 1168–1174. 1856 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact